Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMPL-A830 in Advanced Solid Tumors
NCT07718581Phase 2Recruiting
- Sponsor
- HUTCHMED
- Start
- Sep 2026
- Primary completion
- May 2029
- Countries
- 2
01
Overview
A Phase 2 trial of HMPL-A830 in solid tumor, sponsored by HUTCHMED. Started Sep 2026; status: recruiting.
02
Drugs
HMPL-A830
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07718581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07718581.